Perezone is a naturally occurring sesquiterpene lactone found in the leaves and stems of the plant _Perezia multiflora_. It has attracted considerable attention for its diverse pharmacological activities, including anti-inflammatory, antimicrobial, and anticancer properties. Perezone is known to inhibit the production of pro-inflammatory cytokines, such as TNF-alpha and IL-6. It also exhibits potent antimicrobial activity against a range of bacteria and fungi. Its anticancer properties have been investigated in various studies, demonstrating potential activity against leukemia, breast cancer, and colon cancer cells. Perezone's mode of action is believed to involve modulation of various cellular pathways, including the NF-κB signaling pathway and the apoptotic cascade. Its unique structure and biological activity make it a promising lead compound for the development of new therapeutic agents.'
perezone: isolated from roots of Pereziae adnata; structure given in Merck Index [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 92964 |
| CHEMBL ID | 2071234 |
| SCHEMBL ID | 3609795 |
| MeSH ID | M0152155 |
| Synonym |
|---|
| perezone |
| 3600-95-1 |
| SCHEMBL3609795 |
| l7yl69207z , |
| unii-l7yl69207z |
| 2,5-cyclohexadiene-1,4-dione, 2-(1,5-dimethyl-4-hexenyl)-3-hydroxy-5-methyl-, (r)- |
| CHEMBL2071234 |
| p-benzoquinone, 2-(1,5-dimethyl-4-hexenyl)-3-hydroxy-5-methyl- |
| 2,5-cyclohexadiene-1,4-dione, 2-(1,5-dimethyl-4-hexenyl)-3-hydroxy-5-methyl-, (-)- |
| JZXORCGMYQZBBQ-SNVBAGLBSA-N |
| 2-(1,5-dimethyl-4-hexenyl)-3-hydroxy-5-methylbenzo-1,4-quinone # |
| 2,5-cyclohexadiene-1,4-dione, 2-((1r)-1,5-dimethyl-4-hexen-1-yl)-3-hydroxy-5-methyl- |
| 2-(1,5-dimethyl-4-hexenyl)-3-hydroxy-5-methyl-p-benzoquinone, pipitzahoic acid |
| 2-((1r)-1,5-dimethyl-4-hexen-1-yl)-3-hydroxy-5-methyl-2,5-cyclohexadiene-1,4-dione |
| perezone [mi] |
| 2,5-cyclohexadiene-1,4-dione,2-[(1r)-1,5-dimethyl-4-hexen-1-yl]-3-hydroxy-5-methyl- |
| Q27282818 |
| DTXSID50877865 |
Perezone is an electron-donor and electron-acceptor compound. It behaves similarly to naphtoquinone.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Perezone is an electron-donor and electron-acceptor compound that behaves similarly to naphtoquinone." | ( The action of the sesquiterpenic benzoquinone, perezone, on electron transport in biological membranes. Carabez, A; Sandoval, F, 1988) | 1.25 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Perezone promotes Ca2+ efflux by inducing collapse of the membrane potential and oxidation of pyridine nucleotides." | ( Ca2+ releasing effect of perezone on adrenal cortex mitochondria. Cárabez, A; Chávez, E; Cuéllar, A, 1987) | 1.3 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of perezone on mitochondrial Ca2+ release follows a dose-response relationship and is dependent of the reduction of the drug." | ( Ca2+ releasing effect of perezone on adrenal cortex mitochondria. Cárabez, A; Chávez, E; Cuéllar, A, 1987) | 0.93 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID678020 | Cytotoxicity against human K562 cells after 48 hrs by SRB assay | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678025 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 17.78 uM by spectrophotometry based TBARS assay relative to untreated control | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678023 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 10 uM by spectrophotometry based TBARS assay relative to untreated control | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678024 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation by spectrophotometry based TBARS assay | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID676962 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 100 uM by spectrophotometry based TBARS assay relative to untreated control | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678019 | Cytotoxicity against human PC3 cells after 48 hrs by SRB assay | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678021 | Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678022 | Cytotoxicity against human SKLU1 cells after 48 hrs by SRB assay | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678027 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 56.23 uM by spectrophotometry based TBARS assay relative to untreated control | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| AID678026 | Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 31.62 uM by spectrophotometry based TBARS assay relative to untreated control | 2012 | Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17 | Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (5.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 19 (95.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||